{
    "nctId": "NCT02078531",
    "briefTitle": "A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients",
    "officialTitle": "A Prospective Pilot Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive and Brain Function of Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 130,
    "primaryOutcomeMeasure": "Change the relationship between chemotherapy/anti-hormonal therapy and possible cognitive decline in patients undergoing such therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histologically confirmed stage I-III breast carcinoma\n2. \\<65 years old\n3. Female\n4. Scheduled to receive chemotherapy containing doxorubicin/cyclophosphamide once every 3 weeks for 4 cycles and weekly paclitaxel for 12 cycles starting in either the adjuvant or neoadjuvant setting\n5. May receive adjuvant endocrine therapy subsequently (endocrine therapy can be either tamoxifen or aromatase inhibitors)\n\nInclusion Criteria for Healthy Controls Each subject must meet the following criteria to be enrolled in this study.\n\n1. \\<65 years old\n2. Female\n\nExclusion Criteria:\n\n1. Previous exposure to chemotherapy/anti-hormonal therapy for any other malignancy\n2. Concomitant second primary in-situ or invasive carcinoma or previous history of carcinoma/carcinoma-in-situ\n3. Known disease or injury to the central nervous system (including neurodegenerative diseases, epilepsy), severe visual or auditory disorders\n4. Motor weakness due to any cause which makes using a touchscreen computer difficult\n5. Known background of depression, anxiety disorders or other neurobehavioural conditions\n6. Previous history of cognitive impairment\n7. Ongoing use of tranquilisers or anti-depressants\n8. Previous neuropsychological testing\n9. Current or previous history of alcohol or drug dependence\n\nExclusion Criteria for Healthy Controls\n\nSubjects who meet any of the following criteria will be excluded from the study.\n\n1. Previous exposure to chemotherapy/anti-hormonal therapy for any other malignancy\n2. Concomitant second primary in-situ or invasive carcinoma or previous history of carcinoma/carcinoma-in-situ\n3. Known disease or injury to the central nervous system (including neurodegenerative diseases, epilepsy), severe visual or auditory disorders\n4. Motor weakness due to any cause which makes using a touchscreen computer difficult\n5. Known background of depression, anxiety disorders or other neurobehavioural conditions\n6. Previous history of cognitive impairment\n7. Ongoing use of tranquilisers or anti-depressants\n8. Previous neuropsychological testing\n9. Current or previous history of alcohol or drug dependence",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}